Student-run account by the lab of Lingyin Li (@lingyinli.bsky.social)
lingyinlilab.stanford.edu
www.nature.com/articles/s41...
www.nature.com/articles/s41...
news.stanford.edu/stories/2025...
news.stanford.edu/stories/2025...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
Check out our latest work on HypoxyStat, a small-molecule therapy that increases oxygen-hemoglobin affinity and provides a practical form of hypoxia therapy. A great collaboration with Maze Therapeutics
🔗 Paper: doi.org/10.1016/j.ce... @cp-cell.bsky.social
Check out our latest work on HypoxyStat, a small-molecule therapy that increases oxygen-hemoglobin affinity and provides a practical form of hypoxia therapy. A great collaboration with Maze Therapeutics
🔗 Paper: doi.org/10.1016/j.ce... @cp-cell.bsky.social
Read about the work, now on @biorxivpreprint: www.biorxiv.org/content/10.1....
Read about the work, now on @biorxivpreprint: www.biorxiv.org/content/10.1....
www.vox.com/future-perfe...
www.vox.com/future-perfe...
grc.org/bioorganic-c...